BSX Boston Scientific
- Official Name: BOSTON SCIENTIFIC CORPORATION
- Headquarters: 300 Boston Scientific Way, MARLBOROUGH, MA, 01752-1234 US
- CEO: Michael F. Mahoney
- Website: bostonscientific.com
- Key Investor: BLACKROCK, INC | 9.58%
- Dedicated Investor: BOLLARD GROUP LLC | 54.28%
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-16 | 1 | Won by 0.219 | 0.169 - (0.050) | ||
| 2025-07-23 | 2 | Lost by 0.660 | 3.983 - 4.643 | ||
| 2025-07-29 | 2R | Lost by 0.105 | 1.003 - 1.108 | ||
| 2025-07-30 | 3 | Lost by 1.300 | (0.105) - 1.195 | ||
| 2025-08-06 | 4 | Lost by 5.150 | (4.032) - 1.118 | ||
| 2025-08-07 | 1R | Won by 0.265 | 0.078 - (0.187) | ||
| 2025-08-13 | 5 | Lost by 0.628 | (0.513) - 0.115 | ||
| 2025-08-20 | 6 | Won by 1.320 | 3.214 - 1.894 | ||
| 2025-08-21 | 2R | Lost by 2.287 | (1.006) - 1.281 | ||
| 2025-08-27 | 7 | Lost by 2.799 | (0.168) - 2.631 | ||
| 2025-09-03 | 8 | Won by 1.575 TOTW | 1.713 - 0.138 | ||
| 2025-09-10 | 9 | Lost by 2.594 | (2.114) - 0.480 | ||
| 2025-09-17 | 10 | Lost by 5.920 | (5.060) - 0.860 | ||
| 2025-09-17 | 1R | Lost by 2.180 | (0.437) - 1.743 | ||
| 2025-09-24 | 11 | Won by 1.291 | (0.387) - (1.678) | ||
| 2025-10-01 | 12 | Won by 3.447 | (1.976) - (5.423) | ||
| 2025-10-08 | 13 | Won by 4.077 | 0.862 - (3.215) | ||
| 2025-10-15 | 14 | Won by 2.050 | 0.924 - (1.126) | ||
| 2025-10-22 | 15 | Won by 6.882 | 6.754 - (0.128) |
Latest News

Boston Scientific (BSX) Recalls 262,686 Catheters Over Life Threatening Tip Failure Risk
Boston Scientific (NYSE: BSX) has begun a voluntary worldwide recall of its Imager II Angiographic Catheters due to catheter tip issues. The recall fo...

What Could BSX Stock Be Worth In Three Years?
Boston Scientific (BSX) stock currently trades at 17.2 times earnings. This compares to an average multiple of 55.9 over the last twelve quarter-ends,...

Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance?
J&J's shares fell 5.8% despite an earnings beat and raised guidance, as MedTech weakness, drug sales shortfalls and acquisition costs weighed...

Earnings Preview: What to Expect From Boston Scientific’s Report
Boston Scientific will unveil its fiscal third-quarter results by the end of this month, and analysts forecast a single-digit uptick in its bottom lin...

Global Bioelectronic Medicine Device Market 2026 | Capitalize on 17% CAGR Through 2030 as Medtronic, Abbott, Boston Scientific and LivaNova Advance Closed-Loop Neurostimulation
Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Bioelectronic Medicine Device Market Global Report 2026" has been added to ResearchAndMarkets.com...

Has Medtronic Stock Become A Different Bet?
Medtronic (MDT) stock trades at 21.6 times earnings, sitting about level with the S&P 500 at 21.9. Shareholders paying that market price need to k...

Is Johnson & Johnson (JNJ) Facing New MedTech Risk After A Patent Lawsuit?
Johnson & Johnson (NYSE: JNJ) subsidiary Atraverse Medical has been sued by Boston Scientific over alleged patent infringement tied to a cardiolog...